Arçelik Anonim Sirketi (IST:ARCLK)

Blueprint Medicines Balance Sheet

Financials in millions TRY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60,075	50,816	70,445	40,418	16,015	12,002
Trading Asset Securities	721.67	409.39	654.53	382.34	16.09	27.35
Cash & Short-Term Investments	60,797	51,225	71,100	40,800	16,031	12,030
Cash Growth	33.12%	-27.95%	74.26%	154.51%	33.26%	73.36%
Accounts Receivable	131,044	92,927	96,041	55,949	23,412	12,149
Other Receivables	3,534	4,148	4,001	2,120	1,101	544.49
Receivables	134,578	97,075	100,042	58,069	24,513	12,694
Inventory	94,470	72,696	69,655	51,538	17,087	7,283
Prepaid Expenses	4,414	3,856	2,304	1,043	390.72	309.64
Other Current Assets	8,863	4,615	4,253	2,548	1,574	744.91
Total Current Assets	303,121	229,466	247,353	153,998	59,595	33,061
Property, Plant & Equipment	105,491	92,056	64,637	44,323	13,125	7,297
Long-Term Investments	3,411	2,732	2,307	2,195	885.1	653.63
Goodwill	9,758	8,547	10,495	7,551	2,844	989.06
Other Intangible Assets	43,732	23,462	19,678	14,547	5,249	2,543
Long-Term Accounts Receivable	308.47	34.85	49.27	69.84	45.87	68.23
Long-Term Deferred Tax Assets	30,815	23,029	11,884	3,825	1,824	833.28
Long-Term Deferred Charges	-	12,851	9,052	4,548	1,325	1,021
Other Long-Term Assets	6,175	5,547	7,241	1,364	186.06	83.48
Total Assets	502,812	397,726	372,696	232,422	85,079	46,549
Accounts Payable	123,013	102,390	78,260	50,958	19,669	9,645
Accrued Expenses	46,281	41,186	26,680	14,528	4,955	2,661
Short-Term Debt	85,041	48,936	72,967	30,288	10,254	4,640
Current Portion of Long-Term Debt	45,093	10,889	8,607	26,786	2,460	5,393
Current Portion of Leases	3,602	2,442	1,369	988.06	330.26	201.04
Current Income Taxes Payable	104.13	274.59	609.04	82.82	55.29	7.74
Current Unearned Revenue	929.61	1,161	1,003	361.73	82.92	76.89
Other Current Liabilities	11,666	13,960	9,461	6,888	2,696	1,202
Total Current Liabilities	315,729	221,237	198,956	130,880	40,502	23,827
Long-Term Debt	69,440	69,307	60,059	23,918	18,431	6,128
Long-Term Leases	7,811	6,469	4,133	2,791	1,104	715.89
Long-Term Unearned Revenue	5,177	4,155	3,438	3,223	905.78	527.19
Long-Term Deferred Tax Liabilities	5,913	4,683	4,892	3,379	1,529	563.07
Other Long-Term Liabilities	13,582	9,387	10,313	5,875	615.99	344.16
Total Liabilities	427,601	322,662	286,700	174,383	64,023	32,525
Common Stock	675.73	675.73	675.73	675.73	675.73	675.73
Additional Paid-In Capital	-	-	-	-	0.89	0.89
Retained Earnings	73,709	62,624	60,935	26,454	10,262	8,697
Treasury Stock	-13,211	-11,523	-11,523	-7,981	-1,215	-
Comprehensive Income & Other	7,809	15,394	31,145	33,640	9,661	4,447
Total Common Equity	68,982	67,171	81,233	52,789	19,383	13,820
Minority Interest	6,229	7,893	4,763	5,250	1,672	203.8
Shareholders' Equity	75,211	75,064	85,997	58,039	21,055	14,024
Total Liabilities & Equity	502,812	397,726	372,696	232,422	85,079	46,549
Total Debt	210,987	138,043	147,136	84,771	32,579	17,078
Net Cash (Debt)	-150,190	-86,818	-76,036	-43,972	-16,549	-5,049
Net Cash Per Share	-247.48	-143.06	-125.30	-71.67	-24.88	-7.47
Filing Date Shares Outstanding	606.85	606.85	606.85	606.78	642.18	675.73
Total Common Shares Outstanding	606.85	606.85	606.85	606.78	642.18	675.73
Working Capital	-12,609	8,229	48,397	23,118	19,093	9,234
Book Value Per Share	113.67	110.69	133.86	87.00	30.18	20.45
Tangible Book Value	15,492	35,162	51,060	30,691	11,290	10,288
Tangible Book Value Per Share	25.53	57.94	84.14	50.58	17.58	15.22
Land	-	5,838	3,401	2,456	852.5	303.47
Buildings	-	41,826	30,748	22,024	5,734	3,346
Machinery	-	17,838	19,447	76,794	16,045	9,078
Construction In Progress	-	-	-	4,156	1,022	931.95
Leasehold Improvements	-	-	-	1,102	221.09	133.84

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.